Evidence map›Paper›PMID 31319823›Full record

ArticleBMC biotechnology2019

Crosslinked flagella as a stabilized vaccine adjuvant scaffold.

Casey M Gries, Rohith R Mohan, Dimitrios Morikis, David D Lo

Open access · goldAbstract read
In one paragraph

Article in BMC biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. The Role of Flagellin B inFrontiers in immunology · 2021
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Casey M GriesDivision of Biomedical Sciences, School of Medicine, University of California, Riverside, USA.
Rohith R MohanDepartment of Bioengineering, University of California, Riverside, USA.
Dimitrios MorikisDepartment of Bioengineering, University of California, Riverside, USA.
David D LoDivision of Biomedical Sciences, School of Medicine, University of California, Riverside, USA. david.lo@medsch.ucr.edu.ORCID 0000-0002-5962-9458
University of California, Riverside · US

Funding

Genes regulating M cell differentiationR01AI063426 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI LO, DAVID D · 2005 to 2016
$3.6M
M cell induction and function in mucosal tissuesR56AI063426 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI LO, DAVID D · 2017 to 2017
$291k
NIAID NIH HHS R01 AI063426NIAID NIH HHS R56 AI063426
6 · The paper itself

Abstract

backgroundEngineered vaccine proteins incorporating both antigen and adjuvant components are constructed with the aim of combining functions to induce effective protective immunity. Bacterial flagellin is a strong candidate for an engineered vaccine scaffold as it is known to provide adjuvant activity through its TLR5 and inflammasome activation. Moreover, polymerized flagellin filaments can elicit a more robust immunoglobulin response than monomeric flagellin, and the multimeric antigen form can also promote T cell-independent antibody responses. Here, we aim to produce and test a covalently stabilized polymerized flagellar filament, providing additional immune efficacy through stabilization of its polymeric filament structure, as well as stabilization for long-term storage.

resultsComputational modeling of monomer packing in flagellin filaments helped identify amino acids with proximity to neighboring flagella protofilaments. Paired cysteine substitutions were made at amino acids predicted to form inter-monomer disulfide cross-links, and these substitutions were capable of forming flagella when transfected into a flagellin-negative strain of Salmonella enterica subspecies Typhimurium. Interestingly, each paired substitution stabilized different helical conformational polymorphisms; the stabilized filaments lost the ability to transition between conformations, reducing bacterial motility. More importantly, the paired substitutions enabled extensive disulfide cross links and intra-filament multimer formation, and in one of the three variants, permitted filament stability in high acidic and temperature conditions where wild-type filaments would normally rapidly depolymerize. In addition, with regard to potential adjuvant activity, all crosslinked flagella filaments were able to induce wild-type levels of epithelial NF-κB in a cell reporter system. Finally, bacterial virulence was unimpaired in epithelial adherence and invasion, and the cysteine substitutions also appeared to increase bacterial resistance to oxidizing and reducing conditions.

conclusionsWe identified amino acid pairs, with cysteine substitutions, were able to form intermolecular disulfide bonds that stabilized the resulting flagellar filaments in detergent, hydrochloric acid, and high temperatures while retaining its immunostimulatory function. Flagellar filaments with disulfide-stabilized protofilaments introduce new possibilities for the application of flagella as a vaccine adjuvant. Specifically, increased stability and heat tolerance permits long-term storage in a range of temperature environments, as well as delivery under a range of clinical conditions.

Indexed as

Bacterial ProteinsBacterial VaccinesCross-Linking ReagentsDisulfidesFlagellaFlagellinModels, MolecularProtein ConformationProtein MultimerizationSalmonella typhimuriumBacterial ProteinsBacterial VaccinesCross-Linking ReagentsDisulfidesFlagellinInnate immunityPolymerVaccine

Identifiers

PMID31319823
PMCPMC6637544
OpenAlexW2961343775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.